BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32031428)

  • 1. Measurement of bronchial hyperreactivity: comparison of three Nordic dosimetric methods.
    Lassmann-Klee PG; Sundblad BM; Malmberg LP; Sovijärvi ARA; Piirilä P
    Scand J Clin Lab Invest; 2020 May; 80(3):222-229. PubMed ID: 32031428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Provocative dose of methacholine causing a 20% drop in FEV1 should be used to interpret methacholine challenge tests with modern nebulizers.
    Dell SD; Bola SS; Foty RG; Marshall LC; Nelligan KA; Coates AL
    Ann Am Thorac Soc; 2015 Mar; 12(3):357-63. PubMed ID: 25575246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of methacholine challenge tests assessing airway hyperreactivity in asthmatic patients - a multifunctional approach.
    Kraemer R; Smith HJ; Sigrist T; Giger G; Keller R; Frey M
    Respir Res; 2016 Nov; 17(1):154. PubMed ID: 27855687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of percentage fall in FVC at the provocative concentration of methacholine causing a 20% fall in FEV(1) between patients with asymptomatic bronchial hyperresponsiveness and mild asthma.
    Yoo Y; Choung JT; Yu J; Kim DK; Choi SH; Koh YY
    Chest; 2007 Jul; 132(1):106-11. PubMed ID: 17505037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time domain and flow indices of bronchial hyperresponsiveness: association with asthma symptoms, atopy and smoking.
    Miller MR; Sigsgaard T; Omland O; Pedersen OF
    Eur Respir J; 2002 Jul; 20(1):86-91. PubMed ID: 12166587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchial hyperresponsiveness in an adult population in Helsinki: decreased FEV1 , the main determinant.
    Juusela M; Pallasaho P; Sarna S; Piirilä P; Lundbäck B; Sovijärvi A
    Clin Respir J; 2013 Jan; 7(1):34-44. PubMed ID: 22221737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeatability of histamine bronchial challenge and comparability with methacholine bronchial challenge in a population of Australian schoolchildren.
    Peat JK; Salome CM; Bauman A; Toelle BG; Wachinger SL; Woolcock AJ
    Am Rev Respir Dis; 1991 Aug; 144(2):338-43. PubMed ID: 1859057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchoprovocation in children.
    Shapiro GG
    Pediatrician; 1991; 18(4):269-79. PubMed ID: 1796015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeatability of a rapid dosimetric method for methacholine challenge using a pocket turbine spirometer for FEV1 measurements.
    Hedman J; Alanko K; Nieminen MM
    Clin Physiol; 1996 Jul; 16(4):353-9. PubMed ID: 8842571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methacholine dose-response slopes from maximal bronchial challenge tests in asthmatic children: methodological aspects.
    Gamboa T; Neuparth N; Ribeiro da Silva I; Pinto JE; Rendas AB
    Lung; 1997; 175(4):243-52. PubMed ID: 9195552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchial hyperresponsiveness in a population of north Finland with no previous diagnosis of asthma or chronic bronchitis assessed with histamine and methacholine tests.
    Juusela M; Poussa T; Kotaniemi J; Lundbäck B; Sovijärvi A
    Int J Circumpolar Health; 2008 Sep; 67(4):308-17. PubMed ID: 19024801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchial hyperreactivity to methacholine in atopic versus nonatopic asthmatic schoolchildren and preschoolers.
    Castro-Rodriguez JA; Navarrete-Contreras P; Holmgren L; Sanchez I; Caussade S
    J Asthma; 2010 Oct; 47(8):929-34. PubMed ID: 20831466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Asthma Prevalence Using Methacholine Challenge Test in Korean Children from 2010 to 2014.
    Woo H; Samra MS; Lim DH; Kim JH
    J Korean Med Sci; 2021 May; 36(19):e130. PubMed ID: 34002550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of sensitivity and specifity of two bronchial provocation tests with methacholine and hypertonic saline in bronchial hyperreactivity evaluation in asthmatics].
    Piotrowska T; Siergiejko G; Siergiejko Z
    Pol Merkur Lekarski; 2007 Feb; 22(128):126-9. PubMed ID: 17598657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time intervals (3' or 5') between dose steps can influence methacholine challenge test.
    Mariotta S; Sposato B; Ricci A; De Clementi F; Mannino F
    Lung; 2005; 183(1):1-11. PubMed ID: 15793663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond forced exhalation: impulse oscillometry as a promising tool for bronchial hyperresponsiveness evaluation.
    Corral-Blanco M; Díaz Campos RM; Peláez A; Melero Moreno C
    J Asthma; 2024 May; 61(5):427-435. PubMed ID: 37999625
    [No Abstract]   [Full Text] [Related]  

  • 17. Testing bronchial hyper-responsiveness: provocation or peak expiratory flow variability?
    den Otter JJ; Reijnen GM; van den Bosch WJ; van Schayck CP; Molema J; van Weel C
    Br J Gen Pract; 1997 Aug; 47(421):487-92. PubMed ID: 9302787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between asthma control test, pulmonary function tests and non-specific bronchial hyperresponsiveness in assessing the level of asthma control.
    Grzelewska-Rzymowska IF; Mikołajczyk J; Kroczyńska-Bednarek J; Górski P
    Pneumonol Alergol Pol; 2015; 83(4):266-74. PubMed ID: 25985789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spirometry and tests of bronchial hyperresponsiveness in population studies.
    Chan-Yeung M
    Int J Tuberc Lung Dis; 2000 Jul; 4(7):633-8. PubMed ID: 10907766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interest of FEF(25-75) in evaluating bronchial hyperresponsiveness with the methacholine test.
    Muñoz-López F; Ríos-Alcolea M
    Allergol Immunopathol (Madr); 2012; 40(6):352-6. PubMed ID: 21975147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.